Min Luo

609 total citations
37 papers, 446 citations indexed

About

Min Luo is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Min Luo has authored 37 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Nephrology and 5 papers in Surgery. Recurrent topics in Min Luo's work include Acute Kidney Injury Research (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Cancer-related molecular mechanisms research (3 papers). Min Luo is often cited by papers focused on Acute Kidney Injury Research (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Cancer-related molecular mechanisms research (3 papers). Min Luo collaborates with scholars based in China, United States and Hong Kong. Min Luo's co-authors include Wei Cheng, Xuwei Li, Fei Zhao, Yin Luo, Shaobin Duan, Chengyuan Tang, Shao-Bin Duan, Deliang Liu, Liang Lv and Yuyong Tan and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Life Sciences.

In The Last Decade

Min Luo

34 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Luo China 13 144 109 88 58 57 37 446
Chao Yu China 13 265 1.8× 123 1.1× 60 0.7× 45 0.8× 27 0.5× 39 490
Mengya Liang China 14 227 1.6× 18 0.2× 167 1.9× 110 1.9× 39 0.7× 55 676
M. Kevin Barry United States 10 40 0.3× 50 0.5× 198 2.3× 94 1.6× 112 2.0× 12 386
A Gutiérrez Sweden 12 118 0.8× 166 1.5× 77 0.9× 16 0.3× 26 0.5× 29 448
Zhihong Zhang China 13 159 1.1× 55 0.5× 62 0.7× 68 1.2× 94 1.6× 28 596
Jianwei Yang China 10 96 0.7× 42 0.4× 103 1.2× 25 0.4× 138 2.4× 60 449
Karl-Georg Fischer Germany 16 167 1.2× 244 2.2× 231 2.6× 25 0.4× 23 0.4× 27 750
Jaime Ibarrola Spain 18 250 1.7× 69 0.6× 184 2.1× 32 0.6× 77 1.4× 30 772

Countries citing papers authored by Min Luo

Since Specialization
Citations

This map shows the geographic impact of Min Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Luo more than expected).

Fields of papers citing papers by Min Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Luo. The network helps show where Min Luo may publish in the future.

Co-authorship network of co-authors of Min Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Min Luo. A scholar is included among the top collaborators of Min Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Luo. Min Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Min, et al.. (2025). Analysis and application of conditionally symmetric memristive chaotic systems with attractor growth phenomena. Chaos Solitons & Fractals. 200. 117027–117027.
2.
3.
Bian, Jiang, et al.. (2024). BMP10 accelerated spinal astrocytic activation in neuropathic pain via ALK2/smad1/5/8 signaling. Frontiers in Pharmacology. 15. 1426121–1426121. 3 indexed citations
4.
Wang, Hanyu, Feihong Deng, Min Luo, & Xuehong Wang. (2024). Case report: Fecal microbiota transplant for Clostridium difficile infection in a pregnant patient with acute severe ulcerative colitis. Frontiers in Immunology. 15. 1417003–1417003.
5.
Luo, Min, Shigang Lv, Wei Tu, et al.. (2024). Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG). Heliyon. 10(6). e27510–e27510. 1 indexed citations
6.
Luo, Min, et al.. (2023). Methyl protodioscin reduces c-Myc to ameliorate diabetes mellitus erectile dysfunction via downregulation of AKAP12. Diabetes Research and Clinical Practice. 206. 111012–111012. 2 indexed citations
7.
Fan, Yingfang, Tian Tao, Zhixing Guo, et al.. (2022). Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo. Molecular Therapy — Oncolytics. 24. 636–649. 23 indexed citations
8.
Luo, Min, et al.. (2020). Exploring the potential of RhoA inhibitors to improve exercise-recoverable spinal cord injury: A systematic review and meta-analysis. Journal of Chemical Neuroanatomy. 111. 101879–101879. 17 indexed citations
9.
Luo, Min & Yin Luo. (2020). Imperatorin Relieved Ulcerative Colitis by Regulating the Nrf-2/ARE/HO-1 Pathway in Rats. Inflammation. 44(2). 558–569. 21 indexed citations
10.
Zhu, Zheng, Lan Yang, Lihong Wang, et al.. (2020). A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. BMC Cancer. 20(1). 1072–1072. 3 indexed citations
11.
Luo, Min, et al.. (2020). LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p. Biological Research. 53(1). 14–14. 36 indexed citations
12.
Zhang, Zhiqiang, Xiaoran Guo, Kenneth K.W. To, et al.. (2018). Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo. Acta Pharmaceutica Sinica B. 8(4). 563–574. 24 indexed citations
13.
Cheng, Wei, Fei Zhao, Chengyuan Tang, et al.. (2018). Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model. Archives of Toxicology. 92(7). 2245–2257. 52 indexed citations
14.
Luo, Min, Yang Yuan, Wei Cheng, et al.. (2017). A new scoring model for the prediction of mortality in patients with acute kidney injury. Scientific Reports. 7(1). 7862–7862. 27 indexed citations
15.
Lei, Rong, et al.. (2017). Atorvastatin alleviates iodinated contrast media-induced cytotoxicity in human proximal renal tubular epithelial cells. Experimental and Therapeutic Medicine. 14(4). 3309–3313. 11 indexed citations
16.
Liu, Na, Rong Lei, Mimi Tang, et al.. (2017). Autophagy is activated to protect renal tubular epithelial cells against iodinated contrast media-induced cytotoxicity. Molecular Medicine Reports. 16(6). 8277–8282. 11 indexed citations
17.
Zhao, Zilin, et al.. (2016). A randomized study comparing the effectiveness of microwave ablation radioimmunotherapy and postoperative adjuvant chemoradiation in the treatment of non-small cell lung cancer.. PubMed. 21(2). 326–32. 7 indexed citations
18.
Qiu, Zhi-Kun, Jia-Li He, Xu Liu, et al.. (2015). The role of allopregnanolone in the anxiolytic-like effect of free and easy wanderer plus (FEWP), a polyherbal preparation. Neuroscience Letters. 595. 94–98. 2 indexed citations
19.
Luo, Min, Zhan-Zhan Li, Yanyan Li, et al.. (2014). Relationship between red cell distribution width and serum uric acid in patients with untreated essential hypertension. Scientific Reports. 4(1). 7291–7291. 12 indexed citations
20.
Li, Xu, Xudong Xiang, Xiaoying Ji, et al.. (2014). Effects and mechanism of dehydroepiandrosterone on epithelial–mesenchymal transition in bronchial epithelial cells. Experimental Lung Research. 40(5). 211–221. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chao Yu Breakdown of academic impact, for papers by Mengya Liang Breakdown of academic impact, for papers by M. Kevin Barry Breakdown of academic impact, for papers by A Gutiérrez Breakdown of academic impact, for papers by Zhihong Zhang Breakdown of academic impact, for papers by Jianwei Yang Breakdown of academic impact, for papers by Karl-Georg Fischer Breakdown of academic impact, for papers by Jaime Ibarrola
Rankless by CCL
2026